All publications of “Diogo Diniz Gomes Bugano”

3 results

Clinical features and overall survival among elderly cancer patients in a tertiary cancer center

Yuri Philippe Pimentel Vieira Antunes, Diogo Diniz Gomes Bugano, Auro del Giglio, Rafael Aliosha Kaliks, Theodora Karnakis, Lucíola de Barros Pontes

DOI: 10.1590/S1679-45082015AO3067

ABSTRACTObjective To evaluate the epidemiological profile and overall survival of a large population of elderly individuals diagnosed with solid tumors in a tertiary hospital.Methods This retrospective study included patients aged >65 years, diagnosed with solid tumors between January 2007 and December 2011, at Hospital Israelita Albert Einstein, São Paulo, Brazil. The medical records were reviewed to obtain information about clinical variables and overall survival.Results A total of 806 patients were identified, and 58.4% were male. Mean age was 74 years […]

Prevalence of renal insufficiency in elderly cancer patients in a tertiary cancer center

Lucíola de Barros Pontes, Yuri Philippe Pimentel Vieira Antunes, Diogo Diniz Gomes Bugano, Theodora Karnakis, Auro del Giglio, Rafael Aliosha Kaliks

DOI: 10.1590/s1679-45082014ao3003

Objective To estimate the prevalence of abnormal glomerular filtration rate in elderly patients with solid tumors.Methods A retrospective study with patients aged >65 years diagnosed with solid tumors between January 2007 and December 2011 in a cancer center. The following data were collected: sex, age, serum creatinine at the time of diagnosis and type of tumor. Renal function was calculated using abbreviated Modification of Diet in Renal Disease (MDRD) formulae and then staged in accordance with the clinical practice guidelines […]

Cochrane meta-analysis: teicoplanin versus vancomycin for proven or suspected infection

Diogo Diniz Gomes Bugano, Alexandre Biasi Cavalcanti, Anderson Roman Goncalves, Claudia Salvini de Almeida, Eliézer Silva

DOI: 10.1590/s1679-45082011ao2020

ABSTRACTObjective:To compare efficacy and safety of vancomycin versus teicoplanin in patients with proven or suspected infection.Methods:Data Sources: Cochrane Renal Group’s Specialized Register, CENTRAL, MEDLINE, EMBASE, nephrology textbooks and review articles. Inclusion criteria: Randomized controlled trials in any language comparing teicoplanin to vancomycin for patients with proven or suspected infection. Data extraction: Two authors independently evaluated methodological quality and extracted data. Study investigators were contacted for unpublished information. A random effect model was used to estimate the pooled risk ratio (RR) […]